2024-12-23 · ANDA215503
Liraglutide
liraglutide · original submission 1 · status AP.
Open full application timeline →Open selected original record →
FDA application source year
2024 Drugs@FDA peptide applications
8 selected records whose approved original-submission status date falls in 2024. Dates and status codes are attributed to the retained official dataset observation.
Open selected original record →
2024-12-12 · ANDA204468
Glucagon
glucagon · original submission 1 · status AP.
Open full application timeline →Open selected original record →
2024-11-19 · ANDA206697
Exenatide
exenatide synthetic · original submission 1 · status AP.
Open full application timeline →Open selected original record →
2024-10-17 · ANDA217957
Leuprolide
leuprolide acetate · original submission 1 · status AP.
Open full application timeline →Open selected original record →
2024-09-27 · NDA213224
Octreotide
octreotide acetate · original submission 1 · status AP.
Open full application timeline →Open selected original record →
2024-06-04 · NDA218771
Teriparatide
teriparatide · original submission 1 · status AP.
Open full application timeline →Open selected original record →
2024-05-21 · ANDA217193
Lanreotide
lanreotide acetate · original submission 1 · status AP.
Open full application timeline →Open selected original record →
2024-05-02 · ANDA217860
Octreotide
octreotide acetate · original submission 1 · status AP.
Open full application timeline →Open selected original record →